Answers are grounded in this paper and cite their sources.
Background/Objectives: LINE-1 (L1) retrotransposons and the Alu elements they mobilize can generate new genomic insertions, which represent a recognized source of genomic instability in lung cancer. Whether this activity is confined to tumors or also occurs in the surrounding histologically normal lung has remained unclear, because most studies have searched for insertions only in tumors. Methods: We sequenced the whole genomes (~100×) of matched tumor (T), adjacent histologically normal lung (NT) and blood (WB) from 55 patients with lung cancer. We searched both lung tissues symmetrically for tissue-restricted L1 and Alu insertions with xTea, using blood as the constitutional reference, and controlled for recurrent and known polymorphic loci, allele frequency and detection power. Results: Candidate tissue-restricted insertions were detected at comparable levels in T and NT, with no tumor excess at the cohort level, although individual patients differed widely. Burdens in the two lung tissues were correlated within each patient (L1, ρ = 0.84; Alu, ρ = 0.61; both p < 10−5), and Alu burden increased with age. These patterns held among insertions for which the matched tissue had high detection power. Conclusions: Somatic retrotransposition in the lung does not appear to be confined to the tumor. Instead, it may reflect a patient-level propensity shared by the tumor and adjacent normal lung, a hypothesis that warrants long-read validation and comparison with lung tissue from cancer-free individuals.
No takes yet. Share an insight, caveat, or question.
Jacob‐Hirsch et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: